JP2007500126A - グルコース分解産物のレベルが低下している透析溶液 - Google Patents

グルコース分解産物のレベルが低下している透析溶液 Download PDF

Info

Publication number
JP2007500126A
JP2007500126A JP2006521141A JP2006521141A JP2007500126A JP 2007500126 A JP2007500126 A JP 2007500126A JP 2006521141 A JP2006521141 A JP 2006521141A JP 2006521141 A JP2006521141 A JP 2006521141A JP 2007500126 A JP2007500126 A JP 2007500126A
Authority
JP
Japan
Prior art keywords
concentrate
dialysis solution
solution
acidic
dextrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006521141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500126A5 (https=
Inventor
ポール ジースク，
レオ マルティス，
キャロリン チュー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Original Assignee
Baxter Healthcare SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA filed Critical Baxter Healthcare SA
Publication of JP2007500126A publication Critical patent/JP2007500126A/ja
Publication of JP2007500126A5 publication Critical patent/JP2007500126A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1668—Details of containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2024—Separating means having peelable seals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
JP2006521141A 2003-07-25 2004-07-15 グルコース分解産物のレベルが低下している透析溶液 Pending JP2007500126A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/628,065 US7053059B2 (en) 2003-07-25 2003-07-25 Dialysis solutions with reduced levels of glucose degradation products
PCT/US2004/022895 WO2005011631A1 (en) 2003-07-25 2004-07-15 Dialysis solutions with reduced levels of glucose degradation products

Publications (2)

Publication Number Publication Date
JP2007500126A true JP2007500126A (ja) 2007-01-11
JP2007500126A5 JP2007500126A5 (https=) 2007-05-31

Family

ID=34080723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521141A Pending JP2007500126A (ja) 2003-07-25 2004-07-15 グルコース分解産物のレベルが低下している透析溶液

Country Status (5)

Country Link
US (1) US7053059B2 (https=)
EP (1) EP1648410A1 (https=)
JP (1) JP2007500126A (https=)
MX (1) MXPA06000973A (https=)
WO (1) WO2005011631A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962896B2 (en) 2008-02-27 2018-05-08 Fenwal, Inc. Peelable seals including porous inserts

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10155082B2 (en) 2002-04-10 2018-12-18 Baxter International Inc. Enhanced signal detection for access disconnection systems
US7052480B2 (en) 2002-04-10 2006-05-30 Baxter International Inc. Access disconnection systems and methods
US7022098B2 (en) 2002-04-10 2006-04-04 Baxter International Inc. Access disconnection systems and methods
US20040254513A1 (en) * 2002-04-10 2004-12-16 Sherwin Shang Conductive polymer materials and applications thereof including monitoring and providing effective therapy
US20070293441A1 (en) * 2003-09-22 2007-12-20 Baxter International Inc. High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US7384558B2 (en) * 2004-07-26 2008-06-10 Baxter International Inc. Compositions capable of inhibiting reactive oxygen and carbonyl species
US7935070B2 (en) 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
WO2006115067A1 (ja) * 2005-04-20 2006-11-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 腹膜透析液
US8133194B2 (en) * 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
US8211048B2 (en) * 2006-02-22 2012-07-03 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
JP4004523B1 (ja) * 2006-04-21 2007-11-07 株式会社日本トリム 透析液調製用水およびそれを用いた透析液、透析液の製造方法ならびに透析装置
FR2925341A1 (fr) * 2007-12-20 2009-06-26 Gambro Lundia Ab Appareil pour le traitement extracorporel de sang ou plasma recevant plusieurs articles a usage unique
US8114043B2 (en) 2008-07-25 2012-02-14 Baxter International Inc. Electromagnetic induction access disconnect sensor
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
EP2688602B1 (en) 2011-03-23 2019-11-06 NxStage Medical, Inc. Peritoneal dialysis systems, devices, and methods
AU2012272483B2 (en) 2011-06-24 2016-06-16 Lo, Richard W. C. Multi-container systems and uses thereof
EP3482786B1 (en) * 2012-03-23 2023-12-13 NxStage Medical, Inc. Peritoneal dialysis systems and devices
CN103006555B (zh) * 2013-01-05 2014-08-06 四川美大康佳乐药业有限公司 一种羟乙基淀粉注射液及其制备方法
US10518014B2 (en) * 2015-10-30 2019-12-31 Nxstage Medical, Inc. Treatment fluid devices methods and systems
JP7032321B2 (ja) 2016-05-06 2022-03-08 ガンブロ・ルンディア・エービー 配分液体用システム
WO2017191302A1 (en) 2016-05-06 2017-11-09 Gambro Lundia Ab Dialysis concentrate
SG11201910175RA (en) * 2017-05-05 2019-11-28 Fresenius Medical Care Deutschland Gmbh Peritoneal dialysis concentrate, peritoneal dialysis bag and set for continuous ambulatory peritoneal dialysis or automated peritoneal dialysis
WO2018237375A1 (en) 2017-06-24 2018-12-27 Nxstage Medical, Inc. Peritoneal dialysis fluid preparation and/or treatment devices methods and systems
US20190262526A1 (en) 2018-02-28 2019-08-29 Nxstage Medical, Inc. Fluid Preparation and Treatment Devices Methods and Systems

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536469A (en) * 1991-11-18 1996-07-16 Gambro Ab System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system
WO2000023086A2 (en) * 1998-10-20 2000-04-27 Advanced Renal Technologies Buffered compositions for dialysis
EP1008341A1 (en) * 1997-08-22 2000-06-14 Shimizu Pharmaceutical Co., Ltd. Glucose-containing preparation
JP2000245826A (ja) * 1999-02-26 2000-09-12 Jms Co Ltd 中性腹膜透析液
US6277815B1 (en) * 1997-10-31 2001-08-21 Fresenius Medical Care Deutschland Gmbh Solution for peritoneal dialysis
US6309673B1 (en) * 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879280A (en) 1981-09-24 1989-11-07 Fresenius Ag Dialysis solution for use in intraperitoneal dialysis
EP0076355A3 (en) 1981-10-01 1983-05-25 Abbott Laboratories Improved peritoneal dialysis solution
GB8404299D0 (en) 1984-02-18 1984-03-21 Milner Research Ireland Ltd Peritoneal dialysis
GB8300718D0 (en) 1983-01-12 1983-02-16 Milner Research Ireland Ltd Glucose polymer solutions
US4886789A (en) 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US6077836A (en) 1983-01-12 2000-06-20 Ml Laboratotries, Plc Peritoneal dialysis and compositions for use therein
US4604379A (en) 1984-06-18 1986-08-05 Curators Of The University Of Missouri Dialysis solutions containing cross-linked gelatin
JPS61502943A (ja) 1984-06-22 1986-12-18 ビ−チ、リチャ−ド・エル 電解質溶液およびその生体内における使用
DE3428201A1 (de) 1984-07-31 1986-02-06 Laevosan-Gesellschaft mbH & Co. KG, Linz Loesungen fuer die peritonealdialyse
JPS61247466A (ja) 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
DE3689863T2 (de) 1985-06-22 1995-01-05 Ml Lab Plc In kontinuierlicher Peritonealdialyse verwendete Polymere.
GB8521712D0 (en) 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
US4976683A (en) 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
GR870129B (en) 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
DE3812525C1 (https=) 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
DE3821043A1 (de) 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE4123001A1 (de) 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg Pharmazeutische zusammensetzung fuer die peritonealdialyse
DE4242926C2 (de) 1992-12-18 1994-12-15 Fresenius Ag Dialyselösung für die Peritonealdialyse
SG48090A1 (en) 1993-01-19 1998-04-17 Baxter Int Multiple chamber container
US5436232A (en) 1994-01-07 1995-07-25 Laevosan-Gesellschaft Mbh Pharmaceutical composition for peritoneal dialysis
JPH07252137A (ja) 1994-02-21 1995-10-03 Terumo Corp 糖類含有電解質溶液
GB9411009D0 (en) 1994-06-02 1994-07-20 Giltech Ltd Dialysis fluid
SE510030C2 (sv) 1995-08-08 1999-04-12 Gambro Ab Förfarande för blandning av steril medicinsk lösning samt behållare för utförande av förfarandet
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
SE9600631D0 (sv) 1996-02-20 1996-02-20 Gambro Ab Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
GB9714218D0 (en) 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
DE69929550T8 (de) 1998-05-21 2006-12-28 Nipro Corp. Albumin enthaltende Lösung für die Peritonealdialyse
DE69929555T8 (de) 1998-06-17 2007-05-31 Nipro Corp. Verwendung einer Flüssigkeit zur Herstellung einer Dialyselösung für die kontinuierliche rezirkulierende Peritonealdialyse
SG72966A1 (en) * 1998-07-08 2000-05-23 Sumitomo Chemical Co Transition metal compound olefin polymerization catalyst component olefin polymerization catalyst and process for producing olefin polymer
JP2000037452A (ja) 1998-07-21 2000-02-08 Terumo Corp 腹膜透析液
JP4638106B2 (ja) 1999-10-11 2011-02-23 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 医薬的使用のための溶液中における浸透圧剤としての、ｌ−カルニチンおよびそのアルカノイル誘導体の使用
ATE311203T1 (de) 1999-10-15 2005-12-15 Dow Global Technologies Inc Dialyselösung die polyglycol als osmotischen mittels enthält
US6787039B2 (en) 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
EP1377594A4 (en) 2001-04-10 2004-06-30 Danisco Usa Inc POLYMERIZATION OF MONO- AND DISACCHARIDES WITH MONOCARBOXYLIC ACIDS AND LACTONES
WO2003013553A1 (es) 2001-08-10 2003-02-20 Van Dyck Diaz Rodolfo Candelar Fórmula de solución dialítica y procedimiento de diálisis gastrointestinal
DE10217356B4 (de) 2002-04-18 2012-03-29 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536469A (en) * 1991-11-18 1996-07-16 Gambro Ab System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system
EP1008341A1 (en) * 1997-08-22 2000-06-14 Shimizu Pharmaceutical Co., Ltd. Glucose-containing preparation
US6277815B1 (en) * 1997-10-31 2001-08-21 Fresenius Medical Care Deutschland Gmbh Solution for peritoneal dialysis
WO2000023086A2 (en) * 1998-10-20 2000-04-27 Advanced Renal Technologies Buffered compositions for dialysis
JP2000245826A (ja) * 1999-02-26 2000-09-12 Jms Co Ltd 中性腹膜透析液
US6309673B1 (en) * 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962896B2 (en) 2008-02-27 2018-05-08 Fenwal, Inc. Peelable seals including porous inserts

Also Published As

Publication number Publication date
WO2005011631A1 (en) 2005-02-10
MXPA06000973A (es) 2006-04-27
US7053059B2 (en) 2006-05-30
US20050020507A1 (en) 2005-01-27
EP1648410A1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
US7053059B2 (en) Dialysis solutions with reduced levels of glucose degradation products
AU2003299683B2 (en) Biocompatible dialysis fluids containing icodextrins
JP5690040B2 (ja) 重炭酸塩ベースの腹膜透析溶液
JP4778681B2 (ja) 透析療法のためのビカルボネートベースの溶液
US5906978A (en) Method for iron delivery to a patient by transfer from dialysate
US5945449A (en) Sterile bicarbonate concentrate
JP7034933B2 (ja) 透析濃縮液
HK1088535B (en) Biocompatible dialysis fluids containing icodextrins

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070403

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070403

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100726

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101216